In present study, we established a prognostic model consisting of four SFs (DNAJC6, ZC3H13, IGF2BP3, and DDX19B), which could classify HCC patients as high-risk and low-risk subgroups. This evidence concerns the gene DDX19B and hepatocellular carcinoma.